Antineoplastic agents exacerbate periodontal inflammation and aggravate experimental periodontitis

J Clin Periodontol. 2019 Apr;46(4):457-469. doi: 10.1111/jcpe.13101.

Abstract

Aim: This study evaluated the effects of 5-fluorouracil (5-FU) and cisplatin (CIS) in healthy periodontal tissues and in the early stages of experimental periodontitis (EP) in rats.

Methods: One hundred and eighty male rats were divided into three groups, which were submitted to the following systemic treatments: physiological saline solution (PSS); CIS and 5FU. Each group was subdivided into two subgroups: without (NEP) and with (EP) induction of EP. Animals were euthanized at 3, 5 and 7 days post-treatment. Histological, histometric (percentage of bone in the furcation [PBF]) and immunohistochemical (for tumour necrosis factor-α, interleukin-1β and receptor activator of nuclear factor-κB ligand) analyses were performed. Data were statistically analysed.

Results: CIS-NEP and 5FU-NEP showed more inflammation than PSS-NEP at 3, 5 and 7 days. CIS-EP and 5FU-EP showed more inflammation and lower PBF than PSS-EP at all periods of evaluation. 5FU-EP showed lower PBF than CIS-EP at 5 and 7 days.

Conclusion: 5-FU and CIS exacerbated periodontal inflammation and aggravated the progression of EP in its early stages.

Keywords: alveolar bone loss; antineoplastic agents; cisplatin; fluorouracil; periodontal disease; periodontium.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alveolar Bone Loss*
  • Animals
  • Antineoplastic Agents*
  • Inflammation
  • Male
  • Periodontitis*
  • Rats
  • Rats, Wistar

Substances

  • Antineoplastic Agents